Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4796836 | 0.85 | SMN1; SMN2 (0.48) | ALDH1A1TAAR1SMN1; SMN2IDO1DPP4 | |
| SCHEMBL5188519 | 0.85 | CYP3A4 (0.42) | ALDH1A1TSHRCYP3A4PIK3CASMN1; SMN2 | |
| SCHEMBL18185003 | 0.81 | KDM4E (0.46) | ALDH1A1TSHRTAAR1NR4A2CYP3A4 | |
| SCHEMBL19654351 | 0.80 | TSHR (0.43) | ALDH1A1TSHRTAAR1NR4A2CYP3A4 | |
| SCHEMBL18184977 | 0.79 | ALDH1A1 (0.42) | ALDH1A1TSHRTAAR1NR4A2CYP3A4 | |
| SCHEMBL18185048 | 0.79 | ALDH1A1 (0.42) | ALDH1A1TSHRTAAR1NR4A2CYP3A4 | |
| SCHEMBL18184947 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRTAAR1NR4A2CYP3A4 | |
| SCHEMBL12016024 | 0.78 | SMN1; SMN2 (0.39) | TAAR1SMN1; SMN2GAAAKR1B1 | |
| SCHEMBL15352694 | 0.78 | CD44 (0.46) | ALDH1A1TSHRCYP3A4PIK3CADPP4 | |
| SCHEMBL21027998 | 0.78 | SMN1; SMN2 (0.39) | ALDH1A1TAAR1SMN1; SMN2IDO1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3088382-B1 | METHOD FOR PRODUCING NITRO COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-9561998-B2 | Method for producing nitro compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160318846-A1 | METHOD FOR PRODUCING NITRO COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-11-03 | — | — | US | disclosed |
| EP-3088382-A1 | METHOD FOR PRODUCING NITRO COMPOUND | Sumitomo Chemical Company Limited (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-6683213-B1 | CHEMICAL INTERMEDIATES FOR PYRIDINEDICARBOXAMIDE HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |
| EP-1165496-B1 | SUBSTITUTED ANILINE COMPOUNDS | BASF AG (DE) | 2003-07-09 | — | — | EP | disclosed |
| US-6472349-B1 | Pyridine-2,3-dicarboxylic acid diamides | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-29 | — | — | US | disclosed |
| EP-1165515-A1 | PYRIDINE-2,3-DICARBOXYLIC ACID DIAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-02 | — | — | EP | disclosed |
| EP-1165496-A1 | SUBSTITUTED ANILINE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000059868-A1 | SUBSTITUTED ANILINE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000058288-A1 | PYRIDINE-2,3-DICARBOXYLIC ACID DIAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318846-A1 | METHOD FOR PRODUCING NITRO COMPOUND | NOS1, NOS3, NOS2 | ALDH1A1 2305/4885TSHR 1679/4885TAAR1 565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.